Compare DMRA & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | BL |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2020 | 2016 |
| Metric | DMRA | BL |
|---|---|---|
| Price | $20.40 | $27.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 12 |
| Target Price | ★ $46.89 | $38.10 |
| AVG Volume (30 Days) | 607.7K | ★ 712.6K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 121.48 | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | ★ $177,031,000.00 |
| Revenue This Year | N/A | $9.48 |
| Revenue Next Year | N/A | $10.41 |
| P/E Ratio | ★ N/A | $65.91 |
| Revenue Growth | N/A | ★ 43.78 |
| 52 Week Low | $16.50 | $24.70 |
| 52 Week High | $34.89 | $59.57 |
| Indicator | DMRA | BL |
|---|---|---|
| Relative Strength Index (RSI) | 31.99 | 42.05 |
| Support Level | $18.99 | $27.11 |
| Resistance Level | $26.76 | $31.14 |
| Average True Range (ATR) | 1.59 | 1.02 |
| MACD | -0.18 | -0.18 |
| Stochastic Oscillator | 15.83 | 32.37 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.